PF4 and deep vein thrombosis: In the current case, the reproducibility of consistently high PF4 levels after BNT162b2 vaccination and the recurrence of DVT when the PF4 levels were elevated suggests a potential relationship between APS and the BNT162b2 vaccine, indicating that the test results for vaccinated patients at risk of thrombosis should be evaluated with caution.